Abstract
We identified a novel 6-benzyl ether benzoxaborole with potent activity against Mycobacterium tuberculosis. The compound had an MIC of 2 μM in liquid medium. The compound was also able to prevent growth on solid medium at 0.8 μM and was active against intracellular bacteria (50% inhibitory concentration [IC50] 3.6 μM) without cytotoxicity against eukaryotic cells (IC50 100 μM). We isolated resistant mutants (MIC ≥ 100 μM), which had mutations in Rv1683, Rv3068c, and Rv0047c.
| Original language | English |
|---|---|
| Article number | e01205-17 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 61 |
| Issue number | 9 |
| Early online date | 24 Aug 2017 |
| DOIs | |
| Publication status | Published - 1 Sept 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antimicrobial
- Antitubercular
- Drug resistance
Fingerprint
Dive into the research topics of 'A novel 6-benzyl ether benzoxaborole is active against mycobacterium tuberculosis in vitro'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver